Koers AIT Therapeutics Inc OTC Bulletin Board
Aandelen
Medische apparatuur, benodigdheden & distributie
Omzet 2025 * | 9,67 mln. 8,87 mln. | Omzet 2026 * | 31,61 mln. 29 mln. | Marktkapitalisatie | 26,11 mln. 23,96 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2025 * | -44 mln. -40,37 mln. | Nettowinst (verlies) 2026 * | -33 mln. -30,28 mln. | EV/omzet 2025 * | 2,7 x |
Nettoliquiditeiten 2025 * | - 0 | Nettoliquiditeiten 2026 * | - 0 | EV/omzet 2026 * | 0,83 x |
K/w-verhouding 2025 * |
-0,49
x | K/w-verhouding 2026 * |
-0,64
x | Werknemers | - |
Dividendrendement 2025 * |
-
| Dividendrendement 2026 * |
-
| Vrij verhandelbaar | 81,31% |
Recentste transcriptie over AIT Therapeutics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 13-01-17 |
Douglas Larson
DFI | Director of Finance/CFO | 54 | 01-09-21 |
Amir Avniel
PSD | President | 50 | 13-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 01-08-15 |
William Forbes
BRD | Director/Board Member | 62 | 13-08-18 |
Erick Lucera
BRD | Director/Board Member | 56 | 10-08-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,68% | 179 mld. | |
-5,20% | 98,84 mld. | |
-5,38% | 65,34 mld. | |
+15,46% | 45,41 mld. | |
-6,47% | 44,94 mld. | |
+9,74% | 43,76 mld. | |
+14,01% | 29,01 mld. | |
+19,39% | 25,65 mld. | |
-6,53% | 23,32 mld. |